Company
CardiaTec Biosciences
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Applying artificial intelligence on large-scale multiomic data to develop the next generation of cardiovascular disease drug targets
Loading relationship preview